First Foundation Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$260K Buy
3,002
+60
+2% +$5.75K 0.01% 302
2025
Q4
$283K Buy
2,942
+143
+5% +$13.9K 0.01% 285
2025
Q3
$267K Sell
2,799
-16,291
-85% -$1.5M 0.01% 291
2025
Q2
$1.66M Buy
19,090
+2,681
+16% +$227K 0.06% 148
2025
Q1
$1.47M Buy
16,409
+7,855
+92% +$703K 0.06% 143
2024
Q4
$683K Buy
8,554
+943
+12% +$81.6K 0.03% 201
2024
Q3
$685K Sell
7,611
-3,467
-31% -$292K 0.03% 204
2024
Q2
$872K Buy
11,078
+262
+2% +$21.5K 0.03% 176
2024
Q1
$943K Sell
10,816
-575
-5% -$49.1K 0.04% 178
2023
Q4
$938K Sell
11,391
-2,393
-17% -$182K 0.04% 176
2023
Q3
$1.08M Sell
13,784
-2,260
-14% -$189K 0.05% 173
2023
Q2
$1.41M Sell
16,044
-19,247
-55% -$1.66M 0.06% 156
2023
Q1
$2.85M Sell
35,291
-15,287
-30% -$1.25M 0.13% 107
2022
Q4
$3.93M Sell
50,578
-23,732
-32% -$1.92M 0.19% 87
2022
Q3
$6M Sell
74,310
-211,616
-74% -$19M 0.29% 69
2022
Q2
$25.7M Sell
285,926
-49,682
-15% -$5.03M 1.13% 21
2022
Q1
$37.2M Sell
335,608
-24,700
-7% -$2.61M 1.34% 15
2021
Q4
$37.3M Buy
360,308
+73,627
+26% +$8.53M 1.28% 18
2021
Q3
$35.9M Buy
286,681
+1,889
+0.7% +$244K 1.34% 16
2021
Q2
$35.4M Sell
284,792
-2,115
-0.7% -$266K 1.36% 15
2021
Q1
$33.9M Buy
286,907
+81
+0% +$9.49K 1.45% 14
2020
Q4
$33.6M Buy
286,826
+1,845
+0.6% +$203K 1.49% 14
2020
Q3
$29.6M Buy
284,981
+9,620
+3% +$966K 1.37% 14
2020
Q2
$25.3M Sell
275,361
-4,260
-2% -$408K 1.3% 14
2020
Q1
$25.2M Sell
279,621
-10,984
-4% -$1.17M 1.55% 13
2019
Q4
$33M Buy
290,605
+1,573
+0.5% +$173K 1.63% 12
2019
Q3
$31.4M Sell
289,032
-3,361
-1% -$351K 1.68% 12
2019
Q2
$28.5M Sell
292,393
-5,171
-2% -$472K 1.59% 13
2019
Q1
$27.1M Sell
297,564
-14,755
-5% -$1.32M 1.61% 13
2018
Q4
$28.4M Sell
312,319
-7
-0% -$654 1.79% 11
2018
Q3
$30.7M Sell
312,326
-8,909
-3% -$824K 1.7% 13
2018
Q2
$27.5M Sell
321,235
-45,600
-12% -$3.81M 1.62% 17
2018
Q1
$29.4M Buy
366,835
+1,885
+0.5% +$155K 1.64% 20
2017
Q4
$29.5M Buy
364,950
+14,178
+4% +$1.14M 1.59% 18
2017
Q3
$27.3M Buy
350,772
+13,576
+4% +$1.13M 1.55% 20
2017
Q2
$29.9M Buy
337,196
+5,475
+2% +$462K 1.76% 21
2017
Q1
$26.7M Buy
331,721
+27,639
+9% +$2.16M 1.65% 20
2016
Q4
$21.7M Buy
304,082
+1,151
+0.4% +$90.4K 1.42% 24
2016
Q3
$26.2M Sell
302,931
-5,897
-2% -$514K 1.81% 15
2016
Q2
$26.8M Sell
308,828
-4,703
-2% -$380K 1.92% 14
2016
Q1
$23.5M Buy
313,531
+4,819
+2% +$363K 1.71% 18
2015
Q4
$23.7M Sell
308,712
-72,099
-19% -$5.43M 1.62% 18
2015
Q3
$25.5M Buy
380,811
+185,974
+95% +$13.7M 2.09% 12
2015
Q2
$14.4M Buy
+194,837
New +$14.9M 1.15% 33
2014
Q4
Sell
-5,871
Closed -$364K 255
2014
Q3
$364K Buy
5,871
+1,560
+36% +$99.2K 0.04% 162
2014
Q2
$275K Sell
4,311
-106
-2% -$6.44K 0.03% 173
2014
Q1
$272K Buy
4,417
+362
+9% +$21.1K 0.03% 151
2013
Q4
$233K Buy
4,055
+166
+4% +$9.41K 0.03% 161
2013
Q3
$207K Buy
+3,889
New +$209K 0.03% 153

Other funds holding MDT

First Foundation Advisors's MDT Position: Q1 2026 in Review

First Foundation Advisors increased its Medtronic (MDT) stake by 2% in Q1 2026, buying an estimated $5.75K and bringing the position to 3,002 shares worth $260K. The position accounts for 0.01% of the portfolio, ranked #302.

First Foundation Advisors first reported a position in MDT in Q3 2013 and has held it in 49 quarters since. The position peaked at $37.3M in Q4 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • First Foundation Advisors held 3,002 shares of Medtronic worth $260K as of Q1 2026.
  • First Foundation Advisors bought 60 Medtronic shares in Q1 2026, an estimated $5.75K.
  • Medtronic made up 0.01% of First Foundation Advisors's portfolio in Q1 2026, its #302 holding.
  • First Foundation Advisors first reported a position in Medtronic in Q3 2013 and has held it in 49 quarters since.
  • First Foundation Advisors's Medtronic position peaked at $37.3M in Q4 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on First Foundation Advisors's 13F filing for Q1 2026, filed 4 May 2026.